首页> 外文期刊>PLoS Genetics >Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development—Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated Locus
【24h】

Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development—Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated Locus

机译:利用狗基因组寻找涉及神经胶质瘤发展的新候选基因-全基因组关联映射,然后针对性大规模平行测序,确定了一个高度相关的基因座

获取原文
           

摘要

Gliomas are the most common form of malignant primary brain tumors in humans and second most common in dogs, occurring with similar frequencies in both species. Dogs are valuable spontaneous models of human complex diseases including cancers and may provide insight into disease susceptibility and oncogenesis. Several brachycephalic breeds such as Boxer, Bulldog and Boston Terrier have an elevated risk of developing glioma, but others, including Pug and Pekingese, are not at higher risk. To identify glioma-associated genetic susceptibility factors, an across-breed genome-wide association study (GWAS) was performed on 39 dog glioma cases and 141 controls from 25 dog breeds, identifying a genome-wide significant locus on canine chromosome (CFA) 26 (p = 2.8 x 10~(?8)). Targeted re-sequencing of the 3.4 Mb candidate region was performed, followed by genotyping of the 56 SNVs that best fit the association pattern between the re-sequenced cases and controls. We identified three candidate genes that were highly associated with glioma susceptibility: CAMKK2 , P2RX7 and DENR . CAMKK2 showed reduced expression in both canine and human brain tumors, and a non-synonymous variant in P2RX7 , previously demonstrated to have a 50% decrease in receptor function, was also associated with disease. Thus, one or more of these genes appear to affect glioma susceptibility. Author Summary Gliomas are devastating malignant brain tumors that are very rarely curable. Despite extensive research to define pathways and genes involved in the development of disease, there is still an urgent need to improve therapy. Some dog breeds have a considerable elevated risk of glioma, making the dog a suitable model for locating genes potentially of importance also for development of human glioma. In this study we defined a genomic region strongly associated with glioma in dogs. We also showed that this genomic region had likely been under selection in the dog breeds with the highest risk of developing glioma. Sometimes selection for breed specific traits results in amplification of disease causing mutations together with the variant selected for. We located three candidate genes in the identified region: CAMKK2 , P2RX7 and DENR . We performed further functional studies to evaluate the potential role of these genes in both canine and human glioma. By comparing normal and tumor tissue we could show that two of the genes— CAMKK2 and P2RX7 , were affected at the level of gene expression and protein structure, respectively. We propose that further investigation of all three genes could be of interest with potential benefit to both dog and human.
机译:神经胶质瘤是人类最常见的恶性原发性脑瘤形式,第二次最常见的是犬恶性脑瘤,在两种物种中的发生频率相似。狗是人类复杂疾病(包括癌症)的宝贵自发模型,可以提供对疾病易感性和致癌作用的洞察力。一些短头颅病品种,例如Boxer,Bulldog和Boston Terrier,患神经胶质瘤的风险较高,但其他人,包括Pug和Pekingese,则没有较高的风险。为了鉴定神经胶质瘤相关的遗传易感性因素,对39个狗神经胶质瘤病例和来自25个犬种的141个对照进行了杂交全基因组关联研究(GWAS),确定了犬染色体(CFA)上的全基因组重要位点26 (p = 2.8 x 10〜(?8))。对3.4 Mb候选区域进行有针对性的重测序,然后对最适合重测序病例与对照之间关联模式的56个SNV进行基因分型。我们确定了三个与神经胶质瘤易感性高度相关的候选基因:CAMKK2,P2RX7和DENR。 CAMKK2在犬和人脑肿瘤中均表现出降低的表达,P2RX7中的一个非同义变体(先前已证明受体功能降低了50%)也与疾病有关。因此,这些基因中的一个或多个似乎影响神经胶质瘤的易感性。作者摘要神经胶质瘤是毁灭性的恶性脑肿瘤,很少治愈。尽管进行了广泛的研究来确定与疾病发展有关的途径和基因,但仍然迫切需要改善治疗。一些犬种具有相当高的神经胶质瘤风险,这使得该犬成为合适的模型,用于定位对人类神经胶质瘤的发展也可能具有重要意义的基因。在这项研究中,我们定义了与狗神经胶质瘤密切相关的基因组区域。我们还表明,在患有神经胶质瘤的风险最高的犬种中,可能已经选择了该基因组区域。有时,选择特定品种的性状会导致疾病扩增,并导致突变以及所选择的变种。我们在确定的区域中定位了三个候选基因:CAMKK2,P2RX7和DENR。我们进行了进一步的功能研究,以评估这些基因在犬和人神经胶质瘤中的潜在作用。通过比较正常组织和肿瘤组织,我们可以证明两个基因CAMKK2和P2RX7分别在基因表达和蛋白质结构水平上受到影响。我们建议对这三个基因的进一步研究可能对狗和人都有潜在的好处。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号